<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Nursing and Midwifery School Office</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/57019425-33E1-4859-980C-84915C6EFD81"><gtr:id>57019425-33E1-4859-980C-84915C6EFD81</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:surname>Day</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E077D431-5D7D-44E6-A1AA-6FD938F28DA2"><gtr:id>E077D431-5D7D-44E6-A1AA-6FD938F28DA2</gtr:id><gtr:firstName>Jonathan</gtr:firstName><gtr:otherNames>Campbell</gtr:otherNames><gtr:surname>Knowles</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0401378"><gtr:id>632B1530-2BED-4DDD-926A-89446FD3CFAF</gtr:id><gtr:title>Development of a Bioactive Filler Material for Repairing Perianal Fistulae</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0401378</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-04-06</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-11-07</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>61140</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Novel processing for fabricating porous microspheres with high encapsulation efficiencies.</gtr:description><gtr:id>FF6E295A-0E05-45FB-9451-3DD391E26378</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>FD3E20D1C1E</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>TIPS Microspheres</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>31B117D7-8B90-4CA0-B552-6ADA3FDBA48D</gtr:id><gtr:title>Assessment of antimicrobial microspheres as a prospective novel treatment targeted towards the repair of perianal fistulae.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/172ad2140f1500dc44c4d82d1fc1cc11"><gtr:id>172ad2140f1500dc44c4d82d1fc1cc11</gtr:id><gtr:otherNames>Blaker JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>7B907DE2C15</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B85CFC09-6246-4563-89D0-870540C60A50</gtr:id><gtr:title>Novel fabrication techniques to produce microspheres by thermally induced phase separation for tissue engineering and drug delivery.</gtr:title><gtr:parentPublicationTitle>Acta biomaterialia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/172ad2140f1500dc44c4d82d1fc1cc11"><gtr:id>172ad2140f1500dc44c4d82d1fc1cc11</gtr:id><gtr:otherNames>Blaker JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1742-7061</gtr:issn><gtr:outcomeId>56AA3847EF4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BEF4AFD2-80C6-4C1B-89E4-76F5CED1F1ED</gtr:id><gtr:title>Assessment of polymer/bioactive glass-composite microporous spheres for tissue regeneration applications.</gtr:title><gtr:parentPublicationTitle>Tissue engineering. Part A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bec4136b7ed603946eb46f108a09d04"><gtr:id>2bec4136b7ed603946eb46f108a09d04</gtr:id><gtr:otherNames>Keshaw H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1937-3341</gtr:issn><gtr:outcomeId>9BC3DDCEF34</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0401378</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>